| Product Code: ETC10939464 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Vaccine Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Vaccine Market - Industry Life Cycle |
3.4 Egypt Vaccine Market - Porter's Five Forces |
3.5 Egypt Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Egypt Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Egypt Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Egypt Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Egypt Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Egypt Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for vaccination programs |
4.2.2 Growing awareness about the importance of vaccination in preventing diseases |
4.2.3 Rising incidence of infectious diseases in Egypt |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and distribution |
4.3.2 Limited access to healthcare services in rural areas of Egypt |
5 Egypt Vaccine Market Trends |
6 Egypt Vaccine Market, By Types |
6.1 Egypt Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Egypt Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Egypt Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Egypt Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Egypt Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Egypt Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Egypt Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Egypt Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Egypt Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Egypt Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Egypt Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Egypt Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Egypt Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Egypt Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Egypt Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Egypt Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Egypt Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Egypt Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Egypt Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Egypt Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Egypt Vaccine Market Import-Export Trade Statistics |
7.1 Egypt Vaccine Market Export to Major Countries |
7.2 Egypt Vaccine Market Imports from Major Countries |
8 Egypt Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate among targeted population |
8.2 Number of new vaccines introduced in the Egyptian market |
8.3 Percentage increase in public-private partnerships for vaccine distribution |
8.4 Rate of vaccination compliance among different age groups |
9 Egypt Vaccine Market - Opportunity Assessment |
9.1 Egypt Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Egypt Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Egypt Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Egypt Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Egypt Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Egypt Vaccine Market - Competitive Landscape |
10.1 Egypt Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Egypt Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here